Part 7/13:
However, Michaels raises the concern that the majority of patients tend to regain weight after stopping the medication, highlighting that these drugs are generally meant as chronic therapy rather than a cure. This leads to ethical questions about long-term compliance, costs, and patient dependence.
Limitations, Side Effects, and Risks
The discussion delves deeply into the safety profile of GLP-1 drugs. Nadolski acknowledges side effects like nausea, vomiting, and gastrointestinal discomfort, which can be severe for some patients. He references studies showing that up to 50% experience nausea, and a smaller subset may have serious complications such as gallstones, pancreatitis, or even thyroid tumors.